Proteomic Analysis of Transgenic Oilseed Rape ( L.).

Oilseed rape ( L.) is an important cash crop, but transgenic oilseed rape has not been grown on a commercial scale in China. It is necessary to analyze the characteristics of transgenic oilseed rape before commercial cultivation.

Effect of Transgenic Cotton Expressing Bt Cry1Ac or Cry1Ab/Ac Toxins on Lacewing Larvae Mediated by Herbivorous Insect Pests.

A simple food chain (plant, insect pests, and predatory arthropods) in an agro-ecosystem was set up here as a model system to elucidate the potential effect of transgenic (Bt) cotton on non-target organisms. The system included transgenic/non-transgenic cotton, neonate larvae of three herbivorous insects (, , and ), and predatory lacewing larvae ( spp.), which represent the first, second, and third trophic levels, respectively.

Performance of hybrid progeny formed between genetically modified herbicide-tolerant soybean and its wild ancestor.

Gene flow from genetically modified (GM) crops to wild relatives might affect the evolutionary dynamics of weedy populations and result in the persistence of escaped genes. To examine the effects of this gene flow, the growth of F1 hybrids that were formed by pollinating wild soybean (Glycine soja) with glyphosate-tolerant GM soybean (G. max) or its non-GM counterpart was examined in a greenhouse.

Recent advances and safety issues of transgenic plant-derived vaccines.

Transgenic plant-derived vaccines comprise a new type of bioreactor that combines plant genetic engineering technology with an organism's immunological response. This combination can be considered as a bioreactor that is produced by introducing foreign genes into plants that elicit special immunogenicity when introduced into animals or human beings. In comparison with traditional vaccines, plant vaccines have some significant advantages, such as low cost, greater safety, and greater effectiveness.

Overview of expression of hepatitis B surface antigen in transgenic plants.

Hepatitis B virus (HBV), a pathogen for chronic liver infection, afflicts more than 350 million people world-wide. The effective way to control the virus is to take HBV vaccine. Hepatitis B surface antigen (HBsAg) is an effective protective antigen suitable for vaccine development.